Clinical trials sponsored by Xijing Hospital
32
Recruiting trials
15
Conditions studied
Phase breakdown
Early Phase 1 1Phase 1 1Phase 2 1Not applicable 29
Conditions studied
Recruiting trials led by Xijing Hospital
- A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer
- A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque Psoriasis
- A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis
- Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases (ACT-AD)
- Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients
- Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis
- Clinical Efficacy and Safety Assessment of Breast-Conserving Surgery for Central Breast Cancer: A Prospective Randomized Controlled Trial
- Colorectal Cancer Dataset in Xijing Hospital From 2011
- Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
- Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis
- Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients
- Efficacy and Mechanism of rTMS on the Symptoms of Pleasure Deficit in Adolescent Depression
- Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.
- Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers
- Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.
- Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With Anti-PD-1 Monoclonal Antibody for Stage III Melanoma
- Exploring the Characteristics of Epileptogenic Foci in Drug-Resistant Epilepsy Based on Multimodal Imaging Technology
- Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
- Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
- LAAO Versus NOAC in Patients with AF and PCI
- Liquid Biopsy Multi-Omics and Biomarker Development in Melanoma
- Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis
- Low-dose NOAC Versus GDMT After LAAO
- Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer
- Picankibart in Palmoplantar Pustulosis
- Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
- Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer
- Researching the Useful of Barb Suture in Obese Patients Undergoing Posterior Cervical Surgery
- Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis
- Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
- Study on the Cosmetic Outcome and Safety Evaluation of 3D Printed Biodegradable Biological Mesh for One-Stage Breast Reconstruction After Radical Mastectomy
- Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis
Common questions
How many trials is Xijing Hospital recruiting for?
Xijing Hospital is the lead sponsor of 32 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.